Clinical Trial Update: Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pegylated interferon alfa-2b in children with juvenile pilocytic astrocytoma and optic pathway gliomas has completed; results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Pilocytic Astrocytoma
• Optic Pathway Glioma

Drugs mentioned

• Pegylated Interferon Alfa-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: Emory University | Conditions: Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas | Phase 2 | Status: COMPLETED | Results posted: 2022-01-24